.
.
.
.
Coronavirus

Russia says single-dose Sputnik Light vaccine over 93 pct effective in Paraguay

Published: Updated:

Russia’s single-dose Sputnik Light vaccine against COVID-19 has demonstrated 93.5 percent efficacy in Paraguay, with data taken from the South American country’s vaccination campaign, the Russian Direct Investment Fund (RDIF) said on Wednesday.

For more coronavirus news, visit our dedicated page.

Developed by Moscow’s Gamaleya Institute, Sputnik Light had shown 79.4 percent efficacy when it was first authorized for use in May.

The RDIF, citing data from Paraguay’s health ministry collected by July 30, said the vaccine had proved highly effective among more than 320,000 people.

“The use of the single-component vaccine Sputnik Light allows the Paraguayan authorities to shorten vaccination periods for the population and speed up the formation of collective immunity,” RDIF head Kirill Dmitriev said in a statement.

Read more:

Israel tightens virus restrictions as COVID-19 cases leap

Here are 10 deadly diseases that vaccines helped bring under control

Saudi Arabia extends residency, visit visas until end of Sept amid COVID-19 outbreak